rna-lp vaccine
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 30, 2023 (NCT05660408)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06389591 | Phase 1 | Oct 29, 2024 | National Cancer Institute (NCI), University of Florida |
| NCT05660408 | Phase 1/Phase 2 (Phase 2) | Apr 30, 2023 | University of Florida, V Foundation |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Florida | Academic/Hospital | 2 | 2 | 2 | 2023 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2024 |
| V Foundation | Academic/Hospital | 1 | 0 | 1 | 2023 |
3 organizations
Page 1 / 1